Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bjoern Traenkle

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Ebiomedicine|August 14, 2021
Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on haemodialysisMonika Strengert, Matthias Becker, Gema Morillas Ramos, et al.
Scientific Reports|May 3, 2022
COVID-19 patient serum less potently inhibits ACE2-RBD binding for various SARS-CoV-2 RBD mutantsDaniel Junker, Alex Dulovic, Matthias Becker, et al.
Frontiers in Immunology|October 24, 2022
Longitudinal cellular and humoral immune responses after triple BNT162b2 and fourth full-dose mRNA-1273 vaccination in haemodialysis patientsMatthias Becker, Anne Cossmann, Karsten Lürken, et al.
ACS Infectious Diseases|March 16, 2021
Multiplexed Serum Antibody Screening Platform Using Virus Extracts from Endemic <i>Coronaviridae</i> and SARS-CoV-2Simon Fink, Felix Ruoff, Aaron Stahl, et al.
Frontiers in Immunology|December 27, 2021
Single-Domain Antibodies for Targeting, Detection, and <i>In Vivo</i> Imaging of Human CD4<sup>+</sup> CellsBjoern Traenkle, Philipp D Kaiser, Stefania Pezzana, et al.
Frontiers in Immunology|January 2, 2024
Two birds with one stone: human SIRPα nanobodies for functional modulation and <i>in vivo</i> imaging of myeloid cellsTeresa R Wagner, Simone Blaess, Inga B Leske, et al.
EMBO Reports|April 27, 2021
NeutrobodyPlex-monitoring SARS-CoV-2 neutralizing immune responses using nanobodiesTeresa R Wagner, Elena Ostertag, Philipp D Kaiser, et al.
Nature Communications|May 26, 2021
Immune response to SARS-CoV-2 variants of concern in vaccinated individualsMatthias Becker, Alex Dulovic, Daniel Junker, et al.
Scientific Reports|July 18, 2025
Longitudinal analysis of humoral and cellular immunity in SARS-CoV-2 exposed familiesAlex Dulovic, Armin Rabsteyn, Jonathan Remppis, et al.
Frontiers in Immunology|March 7, 2022
Comparative Magnitude and Persistence of Humoral SARS-CoV-2 Vaccination Responses in the Adult Population in GermanyAlex Dulovic, Barbora Kessel, Manuela Harries, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Ebiomedicine|August 14, 2021
Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on haemodialysisMonika Strengert, Matthias Becker, Gema Morillas Ramos, et al.
Scientific Reports|May 3, 2022
COVID-19 patient serum less potently inhibits ACE2-RBD binding for various SARS-CoV-2 RBD mutantsDaniel Junker, Alex Dulovic, Matthias Becker, et al.
Frontiers in Immunology|October 24, 2022
Longitudinal cellular and humoral immune responses after triple BNT162b2 and fourth full-dose mRNA-1273 vaccination in haemodialysis patientsMatthias Becker, Anne Cossmann, Karsten Lürken, et al.
ACS Infectious Diseases|March 16, 2021
Multiplexed Serum Antibody Screening Platform Using Virus Extracts from Endemic <i>Coronaviridae</i> and SARS-CoV-2Simon Fink, Felix Ruoff, Aaron Stahl, et al.
Frontiers in Immunology|December 27, 2021
Single-Domain Antibodies for Targeting, Detection, and <i>In Vivo</i> Imaging of Human CD4<sup>+</sup> CellsBjoern Traenkle, Philipp D Kaiser, Stefania Pezzana, et al.
Frontiers in Immunology|January 2, 2024
Two birds with one stone: human SIRPα nanobodies for functional modulation and <i>in vivo</i> imaging of myeloid cellsTeresa R Wagner, Simone Blaess, Inga B Leske, et al.
EMBO Reports|April 27, 2021
NeutrobodyPlex-monitoring SARS-CoV-2 neutralizing immune responses using nanobodiesTeresa R Wagner, Elena Ostertag, Philipp D Kaiser, et al.
Nature Communications|May 26, 2021
Immune response to SARS-CoV-2 variants of concern in vaccinated individualsMatthias Becker, Alex Dulovic, Daniel Junker, et al.
Scientific Reports|July 18, 2025
Longitudinal analysis of humoral and cellular immunity in SARS-CoV-2 exposed familiesAlex Dulovic, Armin Rabsteyn, Jonathan Remppis, et al.
Frontiers in Immunology|March 7, 2022
Comparative Magnitude and Persistence of Humoral SARS-CoV-2 Vaccination Responses in the Adult Population in GermanyAlex Dulovic, Barbora Kessel, Manuela Harries, et al.
Pageof 4